BRYAN LAVOIE: Open Payments
NPI 1225468119 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,343 in 135 payments from 25 companies in 2025. Trend: 2023 $2,080 · 2024 $2,693 · 2025 $2,343
Food & beverage: $2,343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $398 |
| ABBVIE INC. | 28 | $298 |
| AstraZeneca Pharmaceuticals LP | 13 | $235 |
| Lilly USA, LLC | 10 | $188 |
| GlaxoSmithKline, LLC. | 10 | $172 |
| PFIZER INC. | 5 | $104 |
| Alnylam Pharmaceuticals Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| Paratek Pharmaceuticals, Inc. | 4 | $74 |
Products named: Wegovy, TRELEGY ELLIPTA, FARXIGA, Ozempic, QULIPTA, MOUNJARO, JARDIANCE, GIVLAARI.
Industry payments across NC — which companies pay providers there.
